Metabolic Tandem Targets: Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus

Medical Council
doi 10.21518/2079-701x-2017-20-20-25
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Remedium, Ltd.